Formulation and Evaluation of Atomoxetine Hydrochloride Sustained Release Tablets

  • Posted on: 30 April 2017
  • By: admin

 

Magazine Home


May 2017 ARTICLE LIST >>

PharmaTutor (May - 2017)

 

ISSN: 2347 - 7881
(Volume 5, Issue 5)

 

Received On: 19/01/2017; Accepted On: 28/01/2017; Published On: 01/05/2017

 

AUTHORS:
Seema Farheen1*, Shaik Zubair1, Alwala Arpini1, Govindapuram Kalpana Goud2,
Saidulu Soppari3, Mangulal Kethavath4
1Department  of pharmaceutics,
Vijaya College Of Pharmacy, Ranga Reddy, Telangana, India.
2Department  of pharmaceutical Analysis and Quality Assurance,
 SLC’S College Of Pharmacy, Nalgonda, Telangana, India.
3Department  of pharmacology,
SLC’S College Of Pharmacy, Nalgonda, Telangana, India.
4Department  of pharmaceutics,
SLC’S College Of Pharmacy, Nalgonda, Telangana, India
* seemafarheen75@gmail.com

 

 

ABSTRACT:
Atomoxetine hydrochloride (atomoxetine) increased the risk of suicidal ideation in short-term studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). Tablets of Atomoxetine Hydrochloride were formulated as sustained release tablet employing tamarind seed polysaccharide, guar gum, PVP, Mg. stearate, MCC  the sustained release tablets was investigated. Sustained release matrix tablets contain Atomoxetine Hydrochloride were developed using different drug polymer concentration of tamarind seed polysaccharide, guar gum.

 

 

How to cite this article: Farheen S, Zubair S, Alwala A, Govindapuram KG, Saidulu S, Kethavath M; Formulation and Evaluation of Atomoxetine Hydrochloride Sustained Release Tablets; PharmaTutor; 2017; 5(5); 76-92

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML